Serum copeptin as a predictor of risk of hyponatremia after transurethral prostatectomy
Background Transurethral resection of the prostate gland (TURP) frequently leads to the development of dilutional hyponatremia. Copeptin has been established as a surrogate marker of vasopressin and is measured for clinical assessment of various sodium and water disturbances. This study aims to asse...
Saved in:
Main Authors: | Katarzyna Bryc-Walczak (Author), Władysław Bryc (Author), Michał Nowicki (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel role of copeptin as a biomarker for the prediction of treatment response in hyponatremia
by: Sang Heon Suh, et al.
Published: (2021) -
Acute coronary syndrome due to midazolam use: Kounis syndrome during a transurethral prostatectomy
by: Ahmet Hakan Ateş, et al.
Published: (2015) -
Association between copeptin levels and treatment responses to hypertonic saline infusion in patients with symptomatic hyponatremia: a prospective cohort study
by: Suryeong Go, et al.
Published: (2021) -
Copeptin: a new predictor for severe obstructive sleep apnea
by: Çınarka H, et al.
Published: (2015) -
A Preliminary, Multicenter, Prospective and Real World Study on the Hemostasis, Coagulation, and Safety of Hemocoagulase Bothrops Atrox in Patients Undergoing Transurethral Bipolar Plasmakinetic Prostatectomy
by: Bing-Hui Li, et al.
Published: (2019)